Tandem Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Sell
27,858
-200
-0.7% -$17.9K 1.21% 23
2026
Q1
$2.02M Sell
28,058
-1,960
-7% -$151K 1.01% 37
2025
Q4
$2.38M Hold
30,018
1.08% 31
2025
Q3
$2.26M Sell
30,018
-100
-0.3% -$6.85K 1.05% 30
2025
Q2
$2.08M Buy
30,118
+105
+0.3% +$6.88K 1.05% 31
2025
Q1
$2.03M Buy
30,013
+7,698
+34% +$461K 1.14% 29
2024
Q4
$1M Buy
+22,315
New +$1.25M 0.54% 52

Other funds holding CVS

Tandem Capital Management's CVS Position: Q2 2026 in Review

Tandem Capital Management reduced its CVS Health (CVS) stake by 0.71% in Q2 2026, selling an estimated $17.9K and leaving 27,858 shares worth $2.88M. The position accounts for 1.21% of the portfolio, ranked #23.

Tandem Capital Management first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Tandem Capital Management held 27,858 shares of CVS Health worth $2.88M as of Q2 2026.
  • Tandem Capital Management sold 200 CVS Health shares in Q2 2026, an estimated $17.9K.
  • CVS Health made up 1.21% of Tandem Capital Management's portfolio in Q2 2026, its #23 holding.
  • Tandem Capital Management first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tandem Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.